eVTOL stocks stopped trading like a single basket on July 7. JOBY closed at $8.92, up 5.06% on 55,707,634 shares, ACHR closed at $5.37, up 7.83% on 35,261,144 shares, and EH closed at $5.78, down 8.48% on 3,168,516 shares. With the U.S. 10-year Treasury yield at 4.48% and the fed funds rate at 3.63%, the macro backdrop stayed restrictive enough that company-specific execution mattered more than sector hype.
For today’s detailed market data, see Joby Daily, Archer Daily, and EHang Daily.
Did the Joby-Toyota 51/49 venture change the production story, or only improve the optics?
The market treated the new manufacturing alliance as real progress, but not as proof that Joby has solved scale economics. That distinction explains why JOBY could rally 5.06% in one session on 55.7 million shares and still finish below its 20-day moving average of $9.22. Price reclaimed the 5-day average at $8.76 and pushed RSI14 back to 47.15, which says the tape improved, yet the chart still stopped short of signaling a clean trend reversal. In other words, investors rewarded the announcement, but they did not re-rate the entire production case in one step.
The structure of the venture is why the story matters. According to Joby’s June 30 release, Toyota contributed 1.02 million shares and Joby contributed 980,000 shares to launch a 51/49 manufacturing joint venture aimed at commercial production capability, productivity, quality, and cost. Benzinga’s follow-up highlighted the same cap-table structure and tied it back to Toyota’s earlier $500 million commitment, which matters because equity investors in this sector have been conditioned to discount partnerships that never make it past branding. This one looks more concrete than that. It is a governance and manufacturing alignment move, not a vague memorandum.
There is also a subtle relative-value point here. Joby’s daily file showed ARKX at 2.43% of fund weight and 2,541,641 shares, which is meaningful but still smaller than Archer’s weight on the same day. That gap suggests investors respect Joby’s strategic positioning, yet they still want clearer evidence that the manufacturing edge can become an execution edge. A company can win the best-partner narrative and still lag in the part of the market that wants immediate milestone visibility.
Still, the market’s caution is rational. The local daily inputs show no fresh number for unit cost, factory throughput, or a certification-linked production milestone that would let investors model a near-term margin improvement. My read: Toyota has materially improved Joby’s execution credibility, but credibility is not yet the same thing as delivered factory leverage. The Virgin Atlantic route story helped reinforce commercialization intent, as TipRanks noted, yet the stock’s failure to reclaim SMA20 says investors still want proof that the production alliance can turn into measurable output.
The directional lean here is constructive, though only moderately so in the short run. I think the market now sees Joby as the peer with the strongest industrial partner, and that matters in a capital-intensive eVTOL cycle where manufacturing mistakes can erase years of certification progress. But until the company pairs the Toyota structure with clearer production metrics, the stock is likely to trade as a promising scale candidate rather than a fully proven one. If JOBY can hold above SMA5 and start pressing through $9.22, the alliance begins to look like a valuation driver instead of just a strategic headline.
Is Archer’s move above $5.20 a certification re-rating, or mostly index-driven momentum?
Archer’s tape looks stronger than a one-day squeeze, even if passive flow is part of the explanation. ACHR closed at $5.37, up 7.83%, and unlike Joby it finished above both its 5-day moving average of $4.94 and its 20-day moving average of $5.20. RSI14 reached 55.56, which is firm but not stretched. The way I see it, that combination matters because it shows buyers paying above recent trend levels instead of merely defending support.
The fundamental backdrop is not a completed certification story, but it is better than it was a few weeks ago. Archer’s recent company disclosure had already established that the program closed Phase 3 and was advancing through Phase 4, the final phase before type-certification readiness. That is why TipRanks framed the rally as a mix of Russell index inclusion and Phase 4 progress rather than as empty speculation. The local daily file adds another useful number: Archer held roughly $1.78 billion in cash and short-term investments, which gives investors more runway to tolerate losses while certification work continues. In this part of the eVTOL cycle, cash is not a side note. It is part of the thesis.
ETF positioning also helps explain why Archer’s move looked more durable than a simple hot-money burst. ARKX showed ACHR at 2.77% of fund weight with 5,463,414 shares, compared with JOBY at 2.43% and 2,541,641 shares. That does not prove superior economics, but it does tell you Archer is being treated as an institutionally ownable expression of the theme. When that fund positioning meets a visible certification milestone and fresh Russell demand, the market has a reason to reward the stock even before the end-state certificate arrives.
One more point matters for tomorrow’s setup: Archer’s technical strength came without an obvious macro tailwind. Rates were not easing, and there was no new company-owned press release inside the reporting window, which means the move had to stand on the combination of narrative durability and buyer demand already in the system. That makes the $5.20 area more important than the session high, because a market that keeps defending fresh support often tells you the story is becoming sticky.
My lean is constructive but still cautious about chasing speed. I would not call Archer fully de-risked, because the market is still pre-paying for the final leg of Phase 4 rather than reacting to a completed milestone. If the timeline stalls, the same buyers supporting the stock now can step back quickly. But today’s setup looks more like an early certification re-rating than a pure momentum mirage. If ACHR keeps holding the $5.20 area as support, investors will increasingly treat the move as evidence that regulatory progress is finally translating into multiple expansion.
Why is EHang still above JPMorgan’s $4.40 target after a 54.6% cut and an 8.48% selloff?
The simplest answer is that EHang is still carrying speculative option value, but that premium is now shrinking under regulatory pressure. JPMorgan cut its price target to $4.40 from $9.70 and downgraded the stock to Underweight, a 54.6% target reduction that would normally force a much sharper reset in a fully institutionalized name. EH did fall 8.48% to $5.78, yet it still closed about 31.4% above the new target. That gap tells you the market has not fully converged on the bank’s valuation framework.
The downgrade itself was serious. The Reuters-sourced summary carried by Investing.com said JPMorgan cited regulatory delays in China, a nationwide suspension of most general aviation activity after the June 26 Beijing accident, and lower revenue expectations for 2026 through 2028. None of that reads like a cosmetic model refresh. It is a direct challenge to the idea that certification progress alone can bridge the gap to commercialization. My view is that the downgrade matters precisely because it shifts the debate away from technology novelty and back toward the timing risk that has always shadowed the name.
Even so, EHang did not capitulate in one session because liquidity and investor composition still matter. EH traded only 3,168,516 shares, far below JOBY’s 55.7 million and ACHR’s 35.3 million. That thinner tape usually produces slower price discovery, especially when a stock still has a residual audience willing to hold for upside optionality. The technical picture supports that interpretation: EH remains below SMA5 at $6.34 and SMA20 at $6.82, while RSI14 sits at 39.91. That is weak, but not yet a full washout. It looks more like a stock sliding through debate than one that has already found a new consensus valuation.
There is also a comparative message in the sector tape. On the same day that EHang sold off, both JOBY and ACHR rallied on manufacturing and certification narratives that were easier for U.S. investors to handicap. EHang, by contrast, is asking the market to underwrite a regulatory path with less near-term clarity and more headline sensitivity. When capital has alternatives inside the same thematic bucket, the name with the most ambiguous policy timeline usually loses sponsorship first.
The directional lean here is cautious to skeptical. I think EH is no longer being priced on confidence; it is being priced on unresolved possibility. As long as regulatory visibility stays cloudy and the stock trades with lighter volume than the U.S. peers, rallies are likely to struggle for durability. If no company-specific positive catalyst appears, the premium above JPMorgan’s target can keep compressing. In that sense, the most important takeaway is not that EHang held above $4.40 for one day, but that the downgrade reopened the question of how much commercialization premium the market is still willing to pay.
What to Watch Tomorrow
First, watch whether JOBY can hold above its $8.76 SMA5 and make another attempt on the $9.22 SMA20, because that would show the Toyota manufacturing story is turning into sustained price support.
Second, watch whether ACHR keeps defending the $5.20 area, since holding above that line would strengthen the case that Phase 4 progress is being re-priced rather than merely rented by momentum traders.
Third, watch whether EH attracts any company-specific catalyst or meaningful volume expansion, because without either one the market may keep compressing the stock toward the new $4.40 target framework.
This is not financial advice. Do your own research.
Follow @futurewatchlog for daily eVTOL coverage.
Previous insight: https://futurewatchlog.com/2026/07/06/evtol-daily-insight-2026-07-06/